Medication errors are systemic failures — and at the moment a nurse pulls a
dose from the cabinet, no systematic check is in place.
Safer-Med is that check: an AI-enabled safety net that re-checks every dose against
the patient’s live
clinical picture, catching two risks others miss — an approved order that has
turned unsafe since it was written, as labs or vitals changed, and an override that
pulls a drug that doesn’t fit the patient.
Safe when written · unsafe two days later · surfaced at the cabinet, in time to review
Platelets fall to 22 K/µL
Full anticoagulant dose on a crashing count — major bleed risk.
HeldCreatinine climbs, eGFR 24
Continuing in acute kidney injury risks lactic acidosis.
HeldSerum K⁺ already 5.9
Another dose pushes toward a fatal arrhythmia.
HeldeGFR drops below 30
NSAID on new renal impairment — AKI and bleeding.
HeldTrough 28, creatinine doubling
Nephrotoxic dose stacking on failing kidneys.
HeldGlucose already 54 mg/dL
A stacked dose drives severe hypoglycemia.
HeldPotassium falls to 2.9
Hypokalemia sharply raises the risk of digoxin toxicity.
HeldThe gap
The automated dispensing cabinet is the last point a medication passes before it reaches the patient. The order was checked when it was written and again at pharmacy review — but it is not re-checked at the cabinet, where the clinical picture may have changed. Three well-documented gaps get past that point, and no single system in today’s stack closes them in real time.
On override, a nurse pulls a medication before any pharmacist reviews the order — and a wrong-drug pull can be fatal. In the widely reported 2017 Vanderbilt case, a nurse using an override withdrew the paralytic vecuronium in place of the sedative Versed, and the patient died. ISMP targets no more than 5% of withdrawals on override; real-world units run well above it.
The order was reviewed when it was written. If a platelet count, a creatinine, or a vital sign changes the picture two days later, nothing re-runs that check at the moment the nurse pulls the dose.
Pharmacy gets a queue. The nurse about to administer gets nothing — and there is usually no closed-loop acknowledgment to tell a pharmacist the dose was held.
The last checkpoint
Every safety check in the chain fires before the dose is pulled for the patient. Safer-Med is the only one that re-checks at the cabinet, after approval — and reaches the nurse holding the dose.
The EMR checks the order for interactions, dose limits, allergies, and more as the prescriber enters it — against the patient’s profile, as it is at that moment.
A pharmacist re-runs those same checks and verifies the order against the patient’s labs, vitals, and history on record at the time of approval.
Hours or days later the nurse pulls the dose. The patient’s labs, vitals or weight may have changed, the order is never re-checked, and an override skips pharmacy review entirely. This is where Safer-Med re-checks against what changed since approval and surfaces it to the nurse in time to review.
Barcode scanning confirms the right drug and the right patient — but not whether a new lab or vital has made the dose unsafe.
Clinical surveillance and EMR advisories add real-time checks too — but they reach pharmacists and prescribers, not the nurse at the cabinet. The moment of dispense is the last checkpoint before the dose reaches the patient.
Why it’s worth solving
≤ 5%
ISMP’s target ceiling for ADC override rates — against real-world units documented starting near 17%.
> $2.5B
Estimated annual U.S. hospital cost of anticoagulant-related adverse drug events — the focus of Joint Commission NPSG.03.05.01.
~$871M
Estimated annual U.S. hospital cost of preventable ADEs from inappropriate medication-related alert overrides.
See the evidence page for the studies behind Safer-Med, each with its setting, sample size and limits.
What we do
Medication errors are systemic failures — so Safer-Med is a systematic safeguard, not just another alert. It sits quietly between the EMR, the cabinets, and the clinical-communications platform your staff already carry, pairing a clinical rule engine with an AI model to add the last-mile check that fires when the patient’s picture changes.
Every new result re-evaluates that patient’s active medications, so an alert is ready to fire at the next dispense or override event — not at the next pharmacist round.
Each withdrawal and override is checked against the patient’s live context — active orders, recent labs and vitals, allergies, ward, and admission — right when the dose is pulled.
The alert reaches the dispensing nurse on the communications app they already use — not a pharmacy queue — and a signed acknowledgment closes the loop back to pharmacy, with escalation when a high-risk alert goes unanswered.
An AI clinical model reads each override — the medication actually pulled — against the whole patient: diagnoses, age, allergies, active therapy, labs. It flags the override that doesn’t fit the patient, like a paralytic drawn instead of a sedative, and surfaces it with its reasoning — so pharmacists review the few overrides that truly warrant a second look, not the whole log.
Why it matters for health systems
Real-time, patient-specific review at the cabinet, aligned to the anticoagulant-safety standard, NPSG.03.05.01, where lab-conditioned risk is highest.
Override review focused on the AI-triaged fraction instead of reading free-text justifications across the board, weeks after the fact.
Every alert and its signed acknowledgment — held or proceeding — captured as a verifiable record for medication-safety governance and quality reporting.
Safer-Med does not replace prescriber order entry, does not modify your cabinets, and never writes back to the EMR. Turning it off changes nothing in your existing workflow.
Questions we get
No. Medication errors are systemic failures, so Safer-Med is a systematic safeguard — not more noise. It fires only when something genuinely warrants it: a risk that is new since pharmacy last reviewed the order, or an override that skipped review entirely — and lab-driven alerts must be corroborated by a recent value, so the one alert that matters isn’t buried. It’s engineered against alert fatigue, not adding to it.
No. Safer-Med is read-only to the EMR and never writes back — no orders, no chart entries. Its output is an alert to a clinician, not an order.
No hardware or firmware change. Safer-Med rides the standard dispense and override events your cabinets already emit; it never locks a drawer or blocks a dispense — it surfaces the finding and asks the nurse to review, in time to act.
It’s engineered against it. A dispense alert fires only when the risk is new since pharmacy last reviewed the order, and lab-driven alerts require a recent corroborating value. You can run everything in silent mode first — per unit and per audience — and measure the volume before a nurse is ever paged.
Safer-Med runs in a single-tenant, isolated cloud environment dedicated to your organization, encrypted in transit and at rest, and HITRUST-aligned. The AI runs under a signed Business Associate Agreement or fully on-premise; no PHI leaves the environment until a BAA is in place.
It uses industry-standard interfaces — HL7 and FHIR for the EMR, standard feeds for the cabinets and your communications platform. Most of the work is a single channel build; your team’s effort is roughly 15–20 hours across setup.
Yes — fully reversible. Safer-Med is a separate component; turning it off has no effect on your EMR or cabinet workflow. Live alerting activates gradually, unit by unit, and only when you choose.
Development partners
AI-enabled medication safety is arriving fast, and the health systems that shape it now will set the standard the rest of the field follows. As a design partner, your pharmacy team helps define how Safer-Med works — tuned to your workflows, clinical behaviors, and priorities — putting your organization at the forefront of a real-time safety category that speaks directly to Joint Commission anticoagulant-safety and override-governance goals.
It is a chance to bring high-value, AI-enabled innovation into your organization: fewer preventable adverse drug events, pharmacist time returned to clinical work, and a measurable, survey-ready safety story.
We’re partnering with only two or three systems. If your organization wants to lead in patient-safety innovation, let’s talk.